Beam Therapeutics
BEAM
BEAM
230 hedge funds and large institutions have $2.02B invested in Beam Therapeutics in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 64 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.46% more ownership
Funds ownership: 95.9% → 98.36% (+2.5%)
4% more capital invested
Capital invested by funds: $1.94B → $2.02B (+$85.1M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
230
Holding in Top 10
2
Calls
$6.96M
Puts
$3.86M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$14M | |
| 3 | +$13.3M | |
| 4 |
CC
Casdin Capital
New York
|
+$11.8M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$11.3M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$21.1M | |
| 3 | -$12.3M | |
| 4 |
Morgan Stanley
New York
|
-$10.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$10M |